AT538116T - 3- (1,3-benyodioxol-5-yl) -6- (4-cyclopropylpiperazin-1-yl) -pyridazine, its salts and solvates and its use as histamine H3-receptor antagonist - Google Patents

3- (1,3-benyodioxol-5-yl) -6- (4-cyclopropylpiperazin-1-yl) -pyridazine, its salts and solvates and its use as histamine H3-receptor antagonist

Info

Publication number
AT538116T
AT538116T AT07729379T AT07729379T AT538116T AT 538116 T AT538116 T AT 538116T AT 07729379 T AT07729379 T AT 07729379T AT 07729379 T AT07729379 T AT 07729379T AT 538116 T AT538116 T AT 538116T
Authority
AT
Austria
Prior art keywords
yl
benyodioxol
cyclopropylpiperazin
pyridazine
solvates
Prior art date
Application number
AT07729379T
Other languages
German (de)
Inventor
Rolf Hohlweg
Original Assignee
High Point Pharmaceuticals Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to EP06114615 priority Critical
Priority to EP06120117 priority
Application filed by High Point Pharmaceuticals Llc filed Critical High Point Pharmaceuticals Llc
Priority to PCT/EP2007/054940 priority patent/WO2007137968A1/en
Publication of AT538116T publication Critical patent/AT538116T/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
AT07729379T 2006-05-29 2007-05-22 3- (1,3-benyodioxol-5-yl) -6- (4-cyclopropylpiperazin-1-yl) -pyridazine, its salts and solvates and its use as histamine H3-receptor antagonist AT538116T (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP06114615 2006-05-29
EP06120117 2006-09-05
PCT/EP2007/054940 WO2007137968A1 (en) 2006-05-29 2007-05-22 3- (1, 3-benz0di0x0l-5-yl) -6- (4-cyclopropylpiperazin-1-yl) -pyridazine, its salts and solvates and its use as histamine h3 receptor antagonist

Publications (1)

Publication Number Publication Date
AT538116T true AT538116T (en) 2012-01-15

Family

ID=38458030

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07729379T AT538116T (en) 2006-05-29 2007-05-22 3- (1,3-benyodioxol-5-yl) -6- (4-cyclopropylpiperazin-1-yl) -pyridazine, its salts and solvates and its use as histamine H3-receptor antagonist

Country Status (23)

Country Link
US (1) US8378097B2 (en)
EP (2) EP2402324A1 (en)
JP (1) JP5694661B2 (en)
KR (1) KR20090040259A (en)
CN (2) CN101460487A (en)
AT (1) AT538116T (en)
AU (1) AU2007267197B2 (en)
BR (1) BRPI0711370A2 (en)
CA (1) CA2659570C (en)
CY (1) CY1112455T1 (en)
DK (1) DK2079732T3 (en)
EA (1) EA016026B1 (en)
ES (1) ES2375872T3 (en)
HR (1) HRP20120227T1 (en)
IL (1) IL194681A (en)
MX (1) MX2008014766A (en)
NZ (1) NZ571972A (en)
PT (1) PT2079732E (en)
RS (1) RS52234B (en)
SG (1) SG163547A1 (en)
SI (1) SI2079732T1 (en)
WO (1) WO2007137968A1 (en)
ZA (1) ZA200808730B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW278229B (en) 1994-12-29 1996-06-11 Siemens Ag Fuse structure for an integrated circuit device and method for manufacturing a fuse structure
AU2006264966B2 (en) 2005-07-04 2013-02-21 High Point Pharmaceuticals, Llc Histamine H3 receptor antagonists
JP2009501733A (en) * 2005-07-20 2009-01-22 メルク フロスト カナダ リミテツド Heteroaromatic compounds as inhibitors of stearoyl Coenzyme a delta-9 desaturase
EP1966183A4 (en) * 2005-12-20 2010-12-29 Merck Frosst Canada Ltd Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
JP2009537596A (en) * 2006-05-23 2009-10-29 ハイ ポイント ファーマシューティカルズ,リミティド ライアビリティ カンパニー 6- (4-cyclopropyl-piperidin-1-yl) -2'-methyl - [3,4 '] - use as bipyridine and its pharmaceutically
DK2079732T3 (en) 2006-05-29 2012-01-23 High Point Pharmaceuticals Llc 3- (1,3-benzodioxol-5-yl) -6- (4-cyclopropyl-piperazin-1-yl) -pyridazine, its salts and solvates and its use as histamine H3 receptor antagonists
NZ611323A (en) 2006-06-23 2014-10-31 Abbvie Bahamas Ltd Cyclopropyl amine derivatives as histamin h3 receptor modulators
US9108948B2 (en) 2006-06-23 2015-08-18 Abbvie Inc. Cyclopropyl amine derivatives
EP2014656A3 (en) * 2007-06-11 2011-08-24 High Point Pharmaceuticals, LLC New heteocyclic h3 antagonists
EP2025674A1 (en) 2007-08-15 2009-02-18 sanofi-aventis Substituted tetra hydro naphthalines, method for their manufacture and their use as drugs
US9186353B2 (en) 2009-04-27 2015-11-17 Abbvie Inc. Treatment of osteoarthritis pain
WO2012037258A1 (en) 2010-09-16 2012-03-22 Abbott Laboratories Processes for preparing 1,2-substituted cyclopropyl derivatives
WO2013151982A1 (en) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Methods and compounds useful in treating pruritus, and methods for identifying such compounds

Family Cites Families (111)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB753166A (en) 1953-05-22 1956-07-18 Miles Lab Improvements in or relating to substituted piperazines
US2993899A (en) * 1958-03-31 1961-07-25 Miles Lab Acetylenically unsaturated piperazine derivatives
US3309370A (en) * 1964-07-16 1967-03-14 Miles Lab Bicycloalkyl piperazine derivatives and process
GB1293565A (en) * 1969-05-03 1972-10-18 Aspro Nicholas Ltd Aminophthalazines and pharmaceutical compositions thereof
US3886161A (en) 1970-12-14 1975-05-27 Sandoz Ag 2-Piperazino-3-cyano-5-phenyl-pyridines
GB1345880A (en) 1971-06-18 1974-02-06 Cepbepe Pyridazine derivatives
DE2516040C2 (en) * 1974-06-10 1984-12-20 Dr. Karl Thomae Gmbh, 7950 Biberach, De
FR2306694B1 (en) 1975-04-07 1980-01-04 Parcor
US3986161A (en) * 1975-04-07 1976-10-12 Sea-Scan, Inc. Underwater directional guidance apparatus
GB1545094A (en) * 1976-12-14 1979-05-02 Gist Brocades Nv Piperazine derivatives
US4144346A (en) * 1977-01-31 1979-03-13 Janssen Pharmaceutica N.V. Novel 1-(1,3-dioxolan-2-ylmethyl)-1H-imidazoles
HU175471B (en) * 1977-06-13 1980-08-28 Gyogyszerkutato Intezet Process for producing new 3-bracketul-pyrazolyl-bracket closed-pyridazine derivatives
US4163849A (en) * 1978-03-17 1979-08-07 Merck & Co., Inc. Piperazinylpyrazines
DE2824764A1 (en) 1978-06-06 1979-12-20 Hoechst Ag New pyridylpiperazinderivate and process for their manufacture
DE3160397D1 (en) 1980-02-22 1983-07-14 Tanabe Seiyaku Co Phenoxyalkane derivative and processes for preparing same
US4339579A (en) * 1980-12-29 1982-07-13 American Home Products Corporation 2,6-Bis-(pyrrolopyrazinyl)pyrazines
US4616014A (en) * 1981-10-22 1986-10-07 Fujisawa Pharmaceutical Co., Ltd. Triazine derivatives, and pharmaceutical compositions comprising the same
US5001125A (en) * 1984-03-26 1991-03-19 Janssen Pharmaceutica N.V. Anti-virally active pyridazinamines
FR2573075B1 (en) * 1984-09-14 1987-03-20 Innothera Lab Sa News (2-pyridyl) -1 piperazines, their process for the preparation and application in therapeutic
WO1986003198A1 (en) * 1984-11-27 1986-06-05 Dainippon Pharmaceutical Co., Ltd. 2-(1-piperazinyl)-4-substituted phenylquinoline derivatives, process for their preparation, and medicinal composition containing same
PH25772A (en) 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation
DK111387A (en) 1986-03-05 1987-09-06 Otsuka Pharma Co Ltd Carbostyril derivatives and salts thereof, pharmaceutical, comprising such derivatives and processes for producing the derivatives
DE3609596A1 (en) * 1986-03-21 1987-10-01 Hoechst Ag 2-azolylmethyl-2-aryl-1,3-dioxolane and their salts, processes for their preparation, compositions containing them and their use
CA1327573C (en) 1987-11-23 1994-03-08 Marcel J. M. Van Der Aa Pyridazinamine derivatives
DE3803860A1 (en) 1988-02-09 1989-08-17 Basf Ag N, n'-disubstituted piperazine
DE3837825A1 (en) 1988-11-08 1990-05-10 Hoechst Ag New insulin derivatives, their use and to a pharmaceutical preparation
DE69010232T2 (en) 1989-03-03 1994-12-01 Dainippon Pharmaceutical Co 2- (1-piperazinyl) -4-phenylcycloalkanpyridin derivatives, processes for their preparation and pharmaceutical compositions containing them.
GB9012316D0 (en) 1990-06-01 1990-07-18 Wellcome Found Pharmacologically active cns compounds
JPH08504798A (en) 1992-12-18 1996-05-21 ザ ウエルカム ファウンデーション リミテッド As enzyme inhibitors, pyrimidine, pyridine, Pteridinone and indazole derivatives
WO1994022846A1 (en) 1993-03-30 1994-10-13 Pfizer Inc. Compounds enhancing antitumor activity of other cytotoxic agents
AT176482T (en) 1993-06-21 1999-02-15 Novo Nordisk As Asp-b28-insulin crystals
NZ273285A (en) 1993-09-17 1997-10-24 Novo Nordisk As Insulin derivatives and compositions thereof
IL111730A (en) * 1993-11-29 1998-12-06 Fujisawa Pharmaceutical Co Piperazine derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
US5504188A (en) 1994-06-16 1996-04-02 Eli Lilly And Company Preparation of stable zinc insulin analog crystals
AU6318896A (en) 1995-07-06 1997-02-05 Japan Tobacco Inc. Benzamidoxime derivatives and medicinal use thereof
US6130217A (en) * 1995-09-20 2000-10-10 Pfizer Inc Compounds enhancing antitumor activity of other cytotoxic agents
PL186204B1 (en) 1995-11-09 2003-11-28 Sanofi-Synthelabo Derivatives of 5-phenyl-3-(piperidin-4-yl)-1,3,4-oxathiazol-2(3h)-one for application as ligands of 5-ht4 or h3 receptor
EP0876379A1 (en) 1996-01-17 1998-11-11 Novo Nordisk A/S Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use
EP0923580A1 (en) 1996-07-26 1999-06-23 Dr. Reddy's Research Foundation Thiazolidinedione compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions thereof
DE69723869D1 (en) 1996-12-31 2003-09-04 Reddys Lab Ltd Dr Heterocyclic compounds, processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
PL192359B1 (en) 1996-08-30 2006-10-31 Novo Nordisk A/S Glp-1 derivatives
DZ2376A1 (en) 1996-12-19 2002-12-28 Smithkline Beecham Plc Sulfonamide derivatives new method for leurpréparation and pharmaceutical compositions ontaining c.
JP4391597B2 (en) 1997-12-02 2009-12-24 ドクター・レディーズ・ラボラトリーズ・リミテッド Antidiabetic, low lipidic and thiazolinedione and oxazolidinedione derivatives having anti-hypertensive
WO1997041119A1 (en) 1997-05-02 1997-11-06 Dr. Reddy's Research Foundation Novel antidiabetic compounds having hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
US6613942B1 (en) 1997-07-01 2003-09-02 Novo Nordisk A/S Glucagon antagonists/inverse agonists
AU749271B2 (en) 1997-07-01 2002-06-20 Agouron Pharmaceuticals, Inc. Glucagon antagonists/inverse agonists
IL133604D0 (en) 1997-07-16 2001-04-30 Novo Nordisk As Fused 1, 2, 4-thiadiazine derivatives, their preparation and use
DE69839887D1 (en) 1997-10-02 2008-09-25 Eisai R&D Man Co Ltd condensed pyridine derivatives
WO1999019313A1 (en) 1997-10-27 1999-04-22 Dr. Reddy's Research Foundation Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them
WO1999021845A2 (en) 1997-10-27 1999-05-06 Agouron Pharmaceuticals, Inc. 4-aminothiazole derivatives, their preparation and their use as inhibitors of cyclin-dependent kinases
US6440961B1 (en) 1997-10-27 2002-08-27 Dr. Reddy's Research Foundation Tricyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
GB9803536D0 (en) 1998-02-19 1998-04-15 Black James Foundation Histamine H,receptor ligands
EP0978512A1 (en) 1998-07-29 2000-02-09 Societe Civile Bioprojet Non-imidazole aryloxy (or arylthio) alkylamines as histamine H3-receptor antagonists and their therapeutic applications
AU6190299A (en) 1998-10-21 2000-05-08 Dr. Reddy's Research Foundation New compounds, their preparation and use
WO2000023416A1 (en) 1998-10-21 2000-04-27 Novo Nordisk A/S New compounds, their preparation and use
JP2002527520A (en) 1998-10-21 2002-08-27 ドクター・レディーズ・リサーチ・ファウンデーション Novel compounds, their preparation and use
JP2002527503A (en) 1998-10-21 2002-08-27 ドクター・レディーズ・リサーチ・ファウンデーション Novel compounds, their preparation and use
JP2002527501A (en) 1998-10-21 2002-08-27 ドクター レディーズ リサーチ ファウンデーション Novel compounds, their preparation and use
EP1123292A1 (en) 1998-10-21 2001-08-16 Dr. Reddy's Research Foundation New compounds, their preparation and use
CZ20011831A3 (en) 1998-12-18 2001-10-17 Novo Nordisk A/S Condensed 1,2,4-thiadiazine derivatives; process of their preparation and use
WO2000041121A1 (en) 1999-01-07 2000-07-13 Ccrewards.Com Method and arrangement for issuance and management of digital coupons and sales offers
AU3033500A (en) 1999-01-15 2000-08-01 Agouron Pharmaceuticals, Inc. Non-peptide glp-1 agonists
WO2000063189A1 (en) 1999-04-16 2000-10-26 Novo Nordisk A/S Crystalline r- guanidines, arginine or (l) -arginine (2s) -2- ethoxy -3-{4- [2-(10h -phenoxazin -10-yl)ethoxy]phenyl}propanoate
CN1351597A (en) 1999-04-16 2002-05-29 雷迪研究基金会 Novel polymorphic forms of an antidiabetic agent, for their preparation and pharmaceutical compositions containing them
AU2953699A (en) 1999-04-16 2000-11-02 Dr. Reddy's Research Foundation Novel polymorphic forms of an antidiabetic agent: process for their preparation and a pharmaceutical composition containing them
EP1171414A1 (en) 1999-04-20 2002-01-16 Novo Nordisk A/S Compounds, their preparation and use
JP2002542237A (en) 1999-04-20 2002-12-10 ノボ ノルディスク アクティーゼルスカブ Novel compounds, their preparation and use
AU3958200A (en) 1999-04-20 2000-11-02 Novo Nordisk A/S New compounds, their preparation and use
JP2002542246A (en) 1999-04-20 2002-12-10 ノボ ノルディスク アクティーゼルスカブ Novel compounds, their preparation and use
WO2000066578A1 (en) 1999-04-30 2000-11-09 Pfizer Products Inc. Compounds for the treatment of obesity
GB9926303D0 (en) 1999-11-05 2000-01-12 Smithkline Beecham Plc Novel compounds
GB9926302D0 (en) 1999-11-05 2000-01-12 Smithkline Beecham Plc Novel compounds
US6602872B1 (en) 1999-12-13 2003-08-05 Merck & Co., Inc. Substituted pyridazines having cytokine inhibitory activity
FR2802206B1 (en) * 1999-12-14 2005-04-22 Sod Conseils Rech Applic Derivatives of 4-aminopiperidine and their use as a drug
NZ519272A (en) 1999-12-16 2004-02-27 Schering Corp Substituted imidazole neuropeptide Y Y5 receptor antagonists
FI20000480A0 (en) 2000-03-01 2000-03-01 Orion Yhtymae Oyj Quinoline and naphthalene-2 ​​alpha antagonists
WO2001066534A2 (en) 2000-03-09 2001-09-13 Abbott Laboratories Cyclic and bicyclic diamino histamine-3 receptor antagonists
AT430730T (en) 2000-03-31 2009-05-15 Ortho Mcneil Pharm Inc histamine receptor antagonists phenyl-substituted indoles as h3
WO2001074810A2 (en) 2000-03-31 2001-10-11 Ortho Mcneil Pharmaceutical, Inc. Method for using 2-aryloxyalkylaminobenzoxazoles and 2-aryloxyalkylaminobenzothiazoles as h3 antagonists
WO2001074813A2 (en) 2000-03-31 2001-10-11 Ortho Mcneil Pharmaceutical, Inc. METHOD FOR USING 2- OR 3-ARYL SUBSTITUTED IMIDAZO[1,2-a] PYRIDINES AS H3 ANTAGONISTS
US6908929B2 (en) 2000-03-31 2005-06-21 Ortho-Mcneil Pharmaceutical, Inc. Phenyl-substituted imidazopyridines
DK1268479T3 (en) 2000-03-31 2004-04-19 Ortho Mcneil Pharm Inc Phenyl-substituted indolizine derivatives and their use as histamine H 3 ligands
PL360373A1 (en) 2000-08-08 2004-09-06 Ortho Mcneil Pharmaceutical, Inc. Non-imidazole aryloxypiperidines as h3 receptor ligands
US6316475B1 (en) * 2000-11-17 2001-11-13 Abbott Laboratories Aminoalkoxybiphenylcarboxamides as histamine-3 receptor ligands and their therapeutic applications
WO2002060392A2 (en) 2001-01-31 2002-08-08 Synaptic Pharmaceutical Corporation Use of gal3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
US20030073672A1 (en) * 2001-09-05 2003-04-17 Breitenbucher J. Guy Method for treating allergies using substituted pyrazoles
US20030236259A1 (en) * 2002-02-05 2003-12-25 Rolf Hohlweg Novel aryl- and heteroarylpiperazines
MXPA04007612A (en) * 2002-02-05 2004-11-10 Novo Nordisk As Novel aryl- and heteroarylpiperazines.
US6864261B2 (en) * 2002-05-02 2005-03-08 Euro-Celtique S.A. Therapeutic agents useful for treating pain
SE0201544D0 (en) * 2002-05-17 2002-05-17 Biovitrum Ab Novel compounds and thier use
US6906060B2 (en) * 2002-06-06 2005-06-14 Novo Nordisk A/S Substituted hexahydropyrrolo[1,2-a]pyrazines, octahydropyrido[1,2-a]-pyrazines and decahydropyrazino[1,2-a]azepines
WO2003104235A1 (en) 2002-06-06 2003-12-18 Novo Nordisk A/S Substituted hexahydropyrrolo[1,2-a]pyrazines, octahydropyrido[1,2-a]pyrazines and decahydropyrazino[1,2-a]azepines
US7332508B2 (en) * 2002-12-18 2008-02-19 Novo Nordisk A/S Substituted homopiperidine, piperidine or pyrrolidine derivatives
ES2342605T3 (en) * 2003-07-29 2010-07-09 High Point Pharmaceuticals, Llc Pyridazinyl piperazines and their use as ligands of the histamine H3 receptor.
CA2551037A1 (en) * 2003-09-22 2005-03-31 Banyu Pharmaceutical Co., Ltd. Novel piperidine derivative
FR2864080B1 (en) * 2003-12-23 2006-02-03 Sanofi Synthelabo Piperazine derivatives of 1-and-1-homopiperazine carboxylate, their preparation and their therapeutic application
EP1737843B1 (en) 2004-04-09 2011-02-23 Merck Sharp & Dohme Corp. Inhibitors of akt activity
CN1984904A (en) 2004-05-08 2007-06-20 神经能质公司 3-aryl-5,6-disubstituted pyridazines
JP5337375B2 (en) 2004-11-02 2013-11-06 ノースウェスタン ユニバーシティ Pyridazine compounds, compositions and methods
BRPI0518907A2 (en) 2004-12-03 2008-12-16 Hoffmann La Roche compounds, process for their manufacture, pharmaceutical compositions comprising them, method for treatment and / or prevenÇço of diseases associated with that estço modulaÇço H3 receptors and their utilizaÇço
GB0501146D0 (en) 2005-01-20 2005-02-23 Astrazeneca Ab Novel benzamide derivatives
US20070078135A1 (en) 2005-04-18 2007-04-05 Neurogen Corporation Substituted heteroaryl CB1 antagonists
FR2885615B1 (en) * 2005-05-12 2007-06-22 Servier Lab New derivatives of phenylpyridinylpiperazine, their process for the preparation and pharmaceutical compositions containing them
FR2885616B1 (en) 2005-05-12 2007-06-22 Servier Lab New derivatives of phenylpyridinylpiperazine, their process for the preparation and pharmaceutical compositions containing them
AU2006264966B2 (en) 2005-07-04 2013-02-21 High Point Pharmaceuticals, Llc Histamine H3 receptor antagonists
UA95454C2 (en) 2005-07-15 2011-08-10 Амр Текнолоджи, Інк. Aryl-and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
AU2006275568A1 (en) 2005-08-02 2007-02-08 Neurogen Corporation Dipiperazinyl ketones and related analogues
JP2009531376A (en) * 2006-03-28 2009-09-03 ハイ ポイント ファーマシューティカルズ,リミティド ライアビリティ カンパニー Benzothiazole having histamine h3 receptor activity
JP2009537596A (en) * 2006-05-23 2009-10-29 ハイ ポイント ファーマシューティカルズ,リミティド ライアビリティ カンパニー 6- (4-cyclopropyl-piperidin-1-yl) -2'-methyl - [3,4 '] - use as bipyridine and its pharmaceutically
DK2079732T3 (en) 2006-05-29 2012-01-23 High Point Pharmaceuticals Llc 3- (1,3-benzodioxol-5-yl) -6- (4-cyclopropyl-piperazin-1-yl) -pyridazine, its salts and solvates and its use as histamine H3 receptor antagonists
EP2014656A3 (en) * 2007-06-11 2011-08-24 High Point Pharmaceuticals, LLC New heteocyclic h3 antagonists

Also Published As

Publication number Publication date
KR20090040259A (en) 2009-04-23
EA016026B1 (en) 2012-01-30
CN102295606A (en) 2011-12-28
HRP20120227T1 (en) 2012-04-30
JP5694661B2 (en) 2015-04-01
EP2079732B9 (en) 2012-03-21
MX2008014766A (en) 2009-03-06
SG163547A1 (en) 2010-08-30
CA2659570A1 (en) 2007-12-06
PT2079732E (en) 2012-02-02
US8378097B2 (en) 2013-02-19
ZA200808730B (en) 2010-02-24
IL194681A (en) 2013-09-30
ES2375872T3 (en) 2012-03-07
WO2007137968A1 (en) 2007-12-06
SI2079732T1 (en) 2012-03-30
RS52234B (en) 2012-10-31
CY1112455T1 (en) 2015-12-09
DK2079732T3 (en) 2012-01-23
AU2007267197A1 (en) 2007-12-06
CA2659570C (en) 2015-10-06
US20090176793A1 (en) 2009-07-09
ES2375872T9 (en) 2012-07-19
EP2079732A1 (en) 2009-07-22
BRPI0711370A2 (en) 2011-11-01
AU2007267197B2 (en) 2011-12-01
NZ571972A (en) 2011-09-30
EP2079732B1 (en) 2011-12-21
EP2402324A1 (en) 2012-01-04
CN101460487A (en) 2009-06-17
JP2009538861A (en) 2009-11-12
EA200870586A1 (en) 2009-10-30

Similar Documents

Publication Publication Date Title
DE602004023840D1 (en) P2X7 receptor antagonists and their use
DE60331061D1 (en) Heterocyclic VEGFR-2 kinase inhibitors
NL1029799A1 (en) Enantiopure aminoheteroarylverbindingen as protein kinase inhibitors.
DE60231394D1 (en) TRIAZOLOÄ4,5-dÜPYRIMIDINDERIVATE AND THEIR USE AS ANTAGONISTS of selected purinergic receptors
AT315554T (en) Diaminothiazoles and their use as cyclin dependent kinase inhibitors
AT461178T (en) Pyridazinyl-piperazine and their use as histamine h3 receptor-ligand
AT547468T (en) Propylene resin composition and use thereof
DK2119715T3 (en) Benzimidazole derivative and its use as AII receptor antagonist
AT344798T (en) As histamine h3 antagonists appropriate indole derivatives
AT531346T (en) Related slidable and rotatable components mateable
DE602005017540D1 (en) Shoulder or hip prosthesis
AT305468T (en) Chinuclidincarbamat derivatives and antagonists whose use as m3
AT423121T (en) Diphenylimidazopyrimidin- and -imidazolamine as b-secretase inhibitors
AT552261T (en) Pyrazole ä1,5-tn pyrimidines as protein kinase inhibitors
DE602005023333D1 (en) kinase inhibitors
DE602006019088D1 (en) Compounds and compositions as protein kinase inhibitors
DE602008003332D1 (en) Hybridbohrmeissel and drilling procedure
AT513855T (en) Antibodies against IL-13 receptor alpha-1 and uses therefor
DE60317466D1 (en) Nicotinamide derivatives as PDE4 inhibitors
DE602005012066D1 (en) Catalyst composition and use thereof
DE602004025504D1 (en) Bicyclic heterocyclic p-38 kinase inhibitors
DE60120494D1 (en) Substituieten triazoldiamin derivatives and their use as kinase inhibitors
DE60137966D1 (en) Anilinopyrimidine derivatives as "jnk pathway inhibitors", compositions and related treatment methods
DE602004016002D1 (en) Benzimidazole, benzothiazol and benzoxazole derivatives and their use as LTA4H-modulators
AT388148T (en) Quinoline derivatives as phosphodiesterase inhibitors